Acknowledgements
NEUROPSYK is support by the Swedish Research Council, Vinnova, FORTE, Formas, Sällskapet Barnavård, the Swedish Association of Local Authorities and Regions, and the Stockholm County Council. We would like to thank all patients who consented to take part in this project. We would also like to thank ADHD-center (Stockholm County Council), Autismcenter för barn och ungdom (Stockholm County Council), BUP KIND (Division of Child and Adolescent Psychiatry, Stockholm County Council), Carmona AB, E-hälsa och IT (Stockholm County Council), Prima Child and Adolescent Psychiatry Järva, Prima Adult Psychiatry Åkersberga, Registercentrum Sydost and SLL-IT Stockholm County Council.
Notes
[1] Conflicts of interest Conflict of Interest statement/disclosure None of the authors reports a direct conflict of interest related to this article. Bölte discloses that he has, in the last 5 years, acted as an author, consultant, or lecturer for Shire, Medice, Roche, Eli Lilly, Prima Psychiatry, GLGroup, System Analytic, Kompetento, Expo Medica, and Prophase. He receives royalties for textbooks and diagnostic tools from Huber/Hogrefe, Kohlhammer, and UTB. Borg has received compensation as a member of the scientific advisory board of Astra Zeneca.